๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Prevalence of hepatitis C antibodies in patient groups in Egypt

โœ Scribed by Nassef F. Hassan


Publisher
Elsevier Science
Year
1993
Tongue
English
Weight
121 KB
Volume
87
Category
Article
ISSN
0035-9203

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Prevalence of antibodies to hepatitis A,
โœ Talarmin, Antoine; Kazanji, Mirdad; Cardoso, Thierry; Pouliquen, Jean-Franรงois; ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 40 KB ๐Ÿ‘ 2 views

In order to determine the prevalence of antibodies to hepatitis A, C, and E viruses (HAV, HCV, and HEV) in the various ethnic groups and areas of French Guiana, sera (996 for HCV and HEV, 941 for HAV) were tested for antibodies to these viruses using ELISAs. Differences in HAV seroprevalence were fo

Prevalence of hepatitis C virus antibodi
โœ Dr. M. Rapicetta; A. F. Attili; A. Mele; A. de Santis; P. Chionne; K. Cristiano; ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 554 KB

## Abstract Several studies had been carried out on antiโ€hepatitis C virus (HCV) prevalence in populations with blood exposure risks and in blood donors. New tests are now available which allow the inโ€ vestigation to extend to other parameters such as antibody type and HCVโ€RNA. In this study the p

Prevalence of hepatitis C virus in famil
โœ Masahide Oshita; Norio Hayashi; Akinori Kasahara; Nobukazu Yuki; Tetsuo Takehara ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 534 KB

## Abstract To investigate the prevalence of hepatitis C virus in the family members of patients with hepatitis C, we examined antibody to hepatitis C virus with a secondโ€generation enzymeโ€linked immunosorbent assay and viral RNA with a combined assay of reverse transcription and polymerase chain r

Prevalence of hepatitis a antibodies in
โœ S. Studer; H. I. Joller-Jemelka; R. Steffen; P. J. Grob ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› Springer ๐ŸŒ English โš– 379 KB

To assess the prevalence of antibodies to hepatitis A virus (anti-HAV) in future travellers, all visitors to the Zurich University Vaccination Center in July/August 1990 were invited to participate in a cross-sectional study. A total of 1126 future travellers were recruited to have a blood sample dr